Email Alert | RSS

Journal of Peking University(Health Sciences) ›› 2019, Vol. 51 ›› Issue (3): 439-444. doi: 10.19723/j.issn.1671-167X.2019.03.010

Previous Articles     Next Articles

Family history of rheumatic diseases in patients with rheumatoid arthritis: a large scale cross-sectional study

Xiao-ying ZHANG1,2,*,Jia-yang JIN1,*,Jing HE1,Yu-zhou GAN1,Jia-li CHEN1,Xiao-zhen ZHAO1,Jia-jia LIU1,Xu-jie YOU1,Xue LI1,Jian-ping GUO1,Xiao-feng LI2,Jing LI1,Ru LI1△(),Zhan-guo LI1△()   

  1. 1. Department of Rheumatology and Immunology, Peking University People’s Hospital; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis(BZ0135), Beijing 100044, China
    2. Department of Rheumatology and Immunology,Second Hospital of Shanxi Medical University, Taiyuan 030001, China
  • Received:2019-03-15 Online:2019-06-18 Published:2019-06-26
  • Contact: Xiao-ying ZHANG,Jia-yang JIN E-mail:doctorliru123@163.com;li99@bjmu.edu.cn
  • Supported by:
    Supported by Tibet Autonomous Region National Science Foundation(XZ2017ZR-ZYZ02)and General Program of Shanxi Youth Science and Technology Research Foundation (2015021180)

RICH HTML

   

PDF (PC)

Abstract: Objective: To determine the associations between the family history of rheumatic diseases and clinical features in patients with rheumatoid arthritis (RA).Methods: In total, eight hundred and ninety patients with RA were enrolled. The demographic and clinical data were collected, including gender, age, height, body weight, age of disease onset, history of smoking and drinking, family history of rheumatic diseases, clinical and laboratory features, pain and global visual analogue scale (VAS), and multi-dimensional health assessment questionnaire (MDHAQ). Finally, 803 patients were completed the dataset and were included in the study. Results: In this cohort, the male/female ratio was 1 ∶3.5, and the age of onset was (45.09±14.50) years. A total of 123 (15.32%) patients were accompanied with family history of rheumatic diseases, including RA, spondyloarthritis, Sj?gren’s syndrome, systemic lupus erythematosus and systemic sclerosis. The percentages of first degree, second degree and both first and second degree relatives were 91 (73.98%), 22 (17.89%), and 10(8.13%) respectively. The most common disease was RA (70.73%), followed by other rheumatic diseases (21.95%), and RA combined with other rheumatic diseases (7.32%). The clinical and laboratory characteristics were compared between the patients with and without family history. The onset-age of the subjects was significantly different between those with and without family history of rheumatic diseases (39.97 ±13.68 vs. 46.01±14.46; P<0.01), which meant that the onset-age in patients with family history was 6.04 years earlier than that in patients without family history. The patients with family history had higher positive rate of rheumatoid factor (RF) compared with those without family history (78.48% vs. 66.67%, P<0.05). By adjusting with gender, body mass index (BMI), smoking and alcohol drinking, anti-cyclic citrullinated peptide (CCP) antibody and RF level, the age at disease onset in the patients with family history was 4.54 years earlier than that in the patients without family history (β=-4.54;95%CI:-8.70, -0.38;P<0.05). Further hierarchical regression analysis showed that, the age at onset of the RA patients with family history was 10.02 years earlier than that without family history among the smoking patients (β= -10.02;95%CI:-17.60, -2.43;P=0.01), while the age at onset of the RA patients with family history was 3.27 years earlier than that without family history among the never smoking patients (β=-3.27;95%CI:-8.37, 1.82;P=0.21).Conclusion: The family history of rheumatic diseases is a risk factor for early onset of RA, and may interact with smoking.

Key words: Rheumatoid arthritis, Family history, Age at onset, Smoking

CLC Number: 

  • R593.22

Table 1

Clinical and demographic features of all participants (n=803)"

Items Total (n=803) Family history of rheumatic disease
No (n=680) Yes (n=123) P
Female,n (%) 624 (77.71) 519 (76.32) 105 (85.37) 0.05
Han nationality,n (%) 715 (95.72) 614 (96.39) 101 (91.82) 0.03
Age/years, x?±s 55.53±13.52 56.20±13.39 51.86±13.69 <0.01
Age at RA onset/years, x?±s 45.09±14.50 46.01±14.46 39.97±13.68 <0.01
History of smoking, n (%) 222 (31.94) 185 (31.46) 37 (34.58) 0.53
History of drinking, n (%) 210 (27.23) 178 (27.30) 32 (26.89) 0.93
Disease duration/years, M (P25, P75) 7.00 (3.00,15.00) 7.00 (3.00,14.00) 10.00 (3.00, 16.00) 0.12
MDHAQ, M (P25, P75) 2.0 (0.0, 6.0) 2.0 (0.0, 6.0) 2.0 (0.0, 6.0) 0.32
Pain VAS, M (P25, P75) 3.0 (1.0, 6.0) 3.0 (1.0, 5.0) 3.0 (1.0, 6.0) 0.15
TJC,M (P25, P75) 2.0 (0.0, 6.0) 2.0 (0.0, 6.0) 2.0 (0.0, 6.0) 0.73
SJC,M (P25, P75) 1.0 (0.0, 4.0) 1.0 (0.0, 4.0) 2.0 (0.0, 4.0) 0.37
DJC,M (P25, P75) 0.0 (0.0, 4.0) 0.0 (0.0, 4.0) 1.0 (0.0,7.0) 0.15
BMI/(kg/m2), x?±s 23.22±3.50 23.35±3.47 22.47±3.61 0.05
CRP/(mg/L),M (P25, P75) 4.68 (1.85, 11.72) 4.88 (2.00, 12.03) 3.40 (1.53, 10.54) 0.07
ESR/(mm/h), M (P25, P75) 19.0 (10.0, 37.8) 19.0 (11.0, 39.0) 17.0 (8.3, 29.5) 0.05
DAS28-CRP,M (P25, P75) 3.1 (2.2, 4.1) 3.0 (2.2, 4.1) 3.1 (2.1, 4.2) 0.96
DAS28-ESR,M (P25, P75) 3.6 (2.7, 4.7) 3.6 (2.7, 4.7) 3.3 (2.5, 4.5) 0.17
Anti-CCP positive, n (%) 509 (85.55) 441 (85.96) 68 (82.93) 0.47
RF-positive, n (%) 394 (68.28) 332 (66.67) 62 (78.48) <0.05

Table 2

Characteristics of family history of rheumatic diseases in RA patients (n=123)"

Relatives RA SpA SS SLE SSc RA with others Total, n (%)
First-degree relatives 70 6 5 5 1 4 91 (73.98)
Second-degree relatives 15 4 2 1 0 0 22 (17.89)
First- and second-degree relatives 2 1 1 1 0 5 10 (8.13)
Total, n (%) 87(70.73) 11 (8.94) 8 (6.51) 7 (5.69) 1(0.81) 9 (7.32) 123 (100.00)

Table 3

The effect of family history on age at onset in RA patients"

Items β(95%CI) P
Non-adjusted -6.04 (-8.79, -3.28) <0.01
Adjusted -4.54 (-8.70, -0.38) <0.05

Table 4

Stratification analysis of risk factors for age at onset of RA and interaction with family history"

Variable n β (95%CI) P (β) P (interaction)
Gender 0.20
Male 179 1.81(-8.81, 12.43) 0.74
Female 624 -6.78(-11.37, -2.20) <0.01
Nation 0.96
Han 715 -5.42(-9.71, -1.13) 0.01
Minority 32 -10.29(-39.73, 19.14) 0.51
Drinking 0.10
No 561 -7.32(-12.13, -2.51) <0.01
Yes 210 0.89(-7.88, 9.66) 0.84
Smoking 0.09
No 473 -3.27(-8.37, 1.82) 0.21
Yes 222 -10.02(-17.60, -2.43) 0.01
BMI/(kg/m2) 0.12
<24 337 -8.83(-14.66, -3.00) <0.01
24-28 145 -2.81(-9.87, 4.25) 0.44
>28 80 1.11(-10.52, 12.74) 0.85
RF 0.79
Negative 183 -5.10(-14.20, 4.00) 0.27
Positive 394 -5.78(-10.52, -1.03) <0.05
Anti-CCP 0.56
Negative 86 -8.92(-20.83, 2.98) 0.15
Positive 509 -4.75(-9.31, -0.19) <0.05
[1] Worthington J . Investigating the genetic basis of susceptibility to rheumatoid arthritis[J]. J Autoimmun, 2005,25(Suppl):16-20.
doi: 10.1016/j.jaut.2005.09.011
[2] Frisell T, Saevarsdottir S, Askling J . Family history of rheumatoid arthritis: an old concept with new developments[J]. Nat Rev Rheumatol, 2016,12(6):335-343.
doi: 10.1038/nrrheum.2016.52
[3] Lawrence, JS. Heberden Oration, 1969. Rheumatoid arthritis-nature ornurture[J] ? Ann Rheum Dis, 1970,29(4):357-379.
doi: 10.1136/ard.29.4.357
[4] Somers EC, Antonsen S, Pedersen L , et al. Parental history of lupus and rheumatoid arthritis and risk in offspring in a nationwide cohort study: does sex matter?[J]. Ann Rheum Dis, 2013,72(4):525-529.
doi: 10.1136/annrheumdis-2011-201165
[5] Laufer VA, Chen JY, Langefeld CD , et al. Integrative approaches to understanding the pathogenic role of genetic variation in rheumatic diseases[J]. Rheum Dis Clin North Am, 2017,43(3):449-466.
doi: 10.1016/j.rdc.2017.04.012
[6] Generali E, Ceribelli A, Stazi MA , et al. Lessons learned from twins in autoimmune and chronic inflammatory diseases[J]. J Autoimmun, 2017,83(9):51-61.
doi: 10.1016/j.jaut.2017.04.005
[7] Wordsworth P, Bell J . Polygenic susceptibility in rheumatoidarthritis[J]. Ann Rheum Dis, 1991,50(6), 343-346.
doi: 10.1136/ard.50.6.343
[8] Hemminki K, Li X, Sundquist J , et al. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions[J]. Arthritis Rheum, 2009,60(3):661-668.
doi: 10.1002/art.v60:3
[9] Okada Y, Wu D, Trynka G , et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery[J]. Nature, 2014,506(7488):376-381.
doi: 10.1038/nature12873
[10] Polderman, TJ, Benyamin B, de Leeuw CA, et al. Meta-analysis of the heritability of human traits based on fifty years of twin stu-dies[J]. Nat Genet, 2015,47(7):702-709.
doi: 10.1038/ng.3285
[11] Khoury MJ, Beaty TH, Liang KY . Can familial aggregation of disease be explained by familial aggregation of environmental risk factors?[J]. Am J Epidemiol, 1988,127(3):674-683.
doi: 10.1093/oxfordjournals.aje.a114842
[12] Jiang X, Frisell T , AsklingJ, et al. To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors?[J]. Arthritis Rheum, 2015,67(2):352-362.
doi: 10.1002/art.v67.2
[13] Frisell T, Holmqvist M, Källberg H , et al. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age[J]. Arthritis Rheum, 2013,65(11):2773-2782.
doi: 10.1002/art.38097
[14] Bang SY, Lee HS, Lee KW , et al. Interaction of HLA-DRB1*0901 and *0405 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope[J]. J Rheumatol, 2013,40(7):1054-1062.
doi: 10.3899/jrheum.121280
[15] Lee HS, Lee KW, Song GG , et al. Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901[J]. Arthritis Rheum, 2004,50(11):3468-3475.
doi: 10.1002/(ISSN)1529-0131
[16] Chibnik LB, Keenan BT, Cui J , et al. Genetic risk score predicting risk of rheumatoid arthritis phenotypes and age of symptom onset[J]. PLoS One, 2011,6(9):e24380.
doi: 10.1371/journal.pone.0024380
[17] Frisell T, Saevarsdottir S, Askling J . Does a family history of RA influence the clinical presentation and treatment response in RA?[J]. Ann Rheum Dis, 2016,75(6):1120-1125
doi: 10.1136/annrheumdis-2015-207670
[18] Kurko J, Besenyei T, Laki J , et al. Genetics of rheumatoid arthritis: a comprehensive review[J]. Clin Rev Allergy Immunol, 2013,45(2):170-179.
doi: 10.1007/s12016-012-8346-7
[19] Diaz FJ, Rojas-Villarraga A, Salazar JC , et al. Anti-CCP antibo-dies are associated with early age at onset in patients with rheumatoid arthritis[J]. Joint Bone Spine, 2011,78(2):175-178.
doi: 10.1016/j.jbspin.2010.07.014
[1] Dongwu LIU, Jie CHEN, Mingli GAO, Jing YU. Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 928-931.
[2] Huina HUANG,Jing ZHAO,Xiangge ZHAO,Ziran BAI,Xia LI,Guan WANG. Regulatory effect of lactate on peripheral blood CD4+ T cell subsets in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 519-525.
[3] Xiaofei TANG,Yonghong LI,Qiuling DING,Zhuo SUN,Yang ZHANG,Yumei WANG,Meiyi TIAN,Jian LIU. Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 279-283.
[4] Xue ZOU,Xiao-juan BAI,Li-qing ZHANG. Effectiveness of tofacitinib combined with iguratimod in the treatment of difficult-to-treat moderate-to-severe rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1013-1021.
[5] Qi WU,Yue-ming CAI,Juan HE,Wen-di HUANG,Qing-wen WANG. Correlation between dyslipidemia and rheumatoid arthritis associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 982-992.
[6] Jing-feng ZHANG,Yin-ji JIN,Hui WEI,Zhong-qiang YAO,Jin-xia ZHAO. Correlation analysis between body mass index and clinical characteristics of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 993-999.
[7] Yin-ji JIN,Lin SUN,Jin-xia ZHAO,Xiang-yuan LIU. Significance of IgA isotype of anti-v-raf murine sarcoma viral oncogene homologue B1 antibody in rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 631-635.
[8] Wen-xin CAI,Shi-cheng LI,Yi-ming LIU,Ru-yu LIANG,Jing LI,Jian-ping GUO,Fan-lei HU,Xiao-lin SUN,Chun LI,Xu LIU,Hua YE,Li-zong DENG,Ru LI,Zhan-guo LI. A cross-sectional study on the clinical phenotypes of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1068-1073.
[9] Fang CHENG,Shao-ying YANG,Xing-xing FANG,Xuan WANG,Fu-tao ZHAO. Role of the CCL28-CCR10 pathway in monocyte migration in rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1074-1078.
[10] Rui LIU,Jin-xia ZHAO,Liang YAN. Clinical characteristics of patients with rheumatoid arthritis complicated with venous thrombosis of lower extremities [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1079-1085.
[11] Jing-feng ZHANG,Yin-ji JIN,Hui WEI,Zhong-qiang YAO,Jin-xia ZHAO. Cross-sectional study on quality of life and disease activity of rheumatoid arthritis patients [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1086-1093.
[12] He-wei MIN,Yi-bo WU,Xin-ying SUN. Relation of smoking status to family health and personality traits in residents aged over 18 years in China [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 483-489.
[13] GAO Chao,CHEN Li-hong,WANG Li,YAO Hong,HUANG Xiao-wei,JIA Yu-bo,LIU Tian. Validation of the Pollard’s classification criteria (2010) for rheumatoid arthritis patients with fibromyalgia [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 278-282.
[14] LOU Xue,LIAO Li,LI Xing-jun,WANG Nan,LIU Shuang,CUI Ruo-mei,XU Jian. Methylation status and expression of TWEAK gene promoter region in peripheral blood of patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1020-1025.
[15] ZHONG Hua,XU Li-ling,BAI Ming-xin,SU Yin. Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1026-1031.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd